Parkinson's Families Project: a UK-wide study of early onset and familial Parkinson's disease

Clodagh Towns,Zih-Hua Fang,Manuela M. X. Tan,Simona Jasaityte,Theresa M. Schmaderer,Eleanor J. Stafford,Miriam Pollard,Russel Tilney,Megan Hodgson,Lesley Wu,Robyn Labrum,Jason Hehir,James Polke,Lara M. Lange,Anthony H.V. Schapira,Kailash P. Bhatia,Parkinsons Families Project (PFP) Study Group,Global Parkinsons Genetics Program (GP2),Andrew Singleton,Cornelis Blauwendraat,Christine Klein,Henry Houlden,Nicholas W. Wood,Paul R. Jarman,Huw R. Morris,Raquel Real

DOI: https://doi.org/10.1101/2023.12.05.23299397

2024-09-10

Abstract:The Parkinson′s Families Project is a UK-wide study aimed at identifying genetic variation associated with familial and early-onset Parkinson′s disease (PD). We recruited individuals with a clinical diagnosis of PD and age at motor symptom onset ≤45 years and/or a family history of PD in up to third-degree relatives. Where possible, we also recruited affected and unaffected relatives. We analysed DNA samples with a combination of single nucleotide polymorphism (SNP) array genotyping, multiplex ligation-dependent probe amplification (MLPA), and whole genome sequencing (WGS). We investigated the association between identified pathogenic mutations and demographic and clinical factors such as age at motor symptom onset, family history, motor symptoms (MDS-UPDRS) and cognitive performance (MoCA). We performed baseline genetic analysis in 718 families, of which 205 had sporadic early-onset PD (sEOPD), 113 had familial early-onset PD (fEOPD) and 400 had late-onset familial PD (fLOPD). 69 (9.6%) of these families carried pathogenic variants in known monogenic PD-related genes. The rate of a molecular diagnosis increased to 28.1% in PD with motor onset ≤ 35 years. We identified pathogenic mutations in in 4.2% of families, and bi-allelic pathogenic mutations in in 3.6% of families. We also identified pathogenic mutations in two families with duplications, and three families with a pathogenic repeat expansion in , as well as single families with pathogenic variants in , , , , , , and . An additional 73 (10.2%) families were carriers of at least one pathogenic or risk variant. Most early-onset and familial PD cases do not have a known genetic cause, indicating that there are likely to be further monogenic causes for PD.